The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1007/s10735-021-09976-y
|View full text |Cite
|
Sign up to set email alerts
|

Nell-1 attenuates lipopolysaccharide-induced inflammation in human dental pulp cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 33 publications
1
9
0
Order By: Relevance
“…Hence, we implied that the influence of IWP‐2 on the immunosuppressive characteristics of hDPSCs was mediated through the p38 MAPK and PI3K signalling pathways. Similar to our results, the previous studies reported that the p38 MAPK inhibitor diminished the anti‐inflammatory response of Nel‐like molecule type 1 (Nell‐1) in LPS‐induced pulpitis rat (Cao et al., 2021). However, all inhibitors did not abolish the effect of IWP‐2 on TGFB1 mRNA expression in LPS‐treated hDPSCs.…”
Section: Discussionsupporting
confidence: 92%
“…Hence, we implied that the influence of IWP‐2 on the immunosuppressive characteristics of hDPSCs was mediated through the p38 MAPK and PI3K signalling pathways. Similar to our results, the previous studies reported that the p38 MAPK inhibitor diminished the anti‐inflammatory response of Nel‐like molecule type 1 (Nell‐1) in LPS‐induced pulpitis rat (Cao et al., 2021). However, all inhibitors did not abolish the effect of IWP‐2 on TGFB1 mRNA expression in LPS‐treated hDPSCs.…”
Section: Discussionsupporting
confidence: 92%
“…Nel-like molecule type 1 (Nell-1) is a compound used as an osteoinductive factor. Human recombinant Nell-1 attenuates p38 and ERK MAPK pathways and decreases expression of IL-6 and IL-8 in LPS-stimulated cells [ 31 ].…”
Section: Resultsmentioning
confidence: 99%
“…13 Accordingly, a recent study found that Nell-1 attenuates lipopolysaccharide (LPS)-induced inflammation in a concentration-dependent manner in vitro. 14 Previous investigations from our group revealed that Nell-1 could modulate the ratio of M2/M1 macrophages in vitro, in particular at a concentration of 200 ng/mL (unpublished data). In addition, Nell-1 is considered as a potential drug candidate in animal models of osteoporosis and osteoarthritis owing to its prochondrogenic effects, promotion of osteoblast differentiation, and inhibition of osteoclast-directed bone resorption, 15,16 supporting a role for Nell-1 in immunity and bone homeostasis.…”
Section: Introductionmentioning
confidence: 85%